Ronald L Korn
Overview
Explore the profile of Ronald L Korn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1381
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arias-Lorza A, Costello J, Hingorani S, Von Hoff D, Korn R, Raghunand N
Sci Rep
. 2024 May;
14(1):11570.
PMID: 38773189
Pre-clinical and clinical studies have shown that PEGPH20 depletes intratumoral hyaluronic acid (HA), which is linked to high interstitial fluid pressures and poor distribution of chemotherapies. 29 patients with metastatic...
2.
Arias-Lorza A, Costello J, Hingorani S, Von Hoff D, Korn R, Raghunand N
Res Sq
. 2023 Sep;
PMID: 37720027
Pre-clinical and clinical studies have shown that PEGPH20 depletes intratumoral hyaluronic acid (HA), which is linked to high interstitial fluid pressures and poor distribution of chemotherapies. 29 patients with metastatic...
3.
Ravi H, Arias-Lorza A, Costello J, Han H, Jeong D, Klinz S, et al.
Radiol Imaging Cancer
. 2023 Feb;
5(2):e220022.
PMID: 36734848
Purpose To investigate ferumoxytol (FMX)-enhanced MRI as a pretreatment predictor of response to liposomal irinotecan (nal-IRI) for thoracoabdominal and brain metastases in women with metastatic breast cancer (mBC). Materials and...
4.
Janku F, Zhang H, Pezeshki A, Goel S, Murthy R, Wang-Gillam A, et al.
Clin Cancer Res
. 2020 Oct;
27(1):96-106.
PMID: 33046513
Purpose: Intratumorally injected -NT (nontoxic; lacking the alpha toxin), an attenuated strain of , replicates within hypoxic tumor regions resulting in tumor-confined cell lysis and inflammatory response in animals, which...
5.
Lorza A, Ravi H, Philip R, Galons J, Trouard T, Parra N, et al.
Sci Rep
. 2020 Sep;
10(1):14449.
PMID: 32879326
The vascular disrupting agent crolibulin binds to the colchicine binding site and produces anti-vascular and apoptotic effects. In a multisite phase 1 clinical study of crolibulin (NCT00423410), we measured treatment-induced...
6.
Korn R, Rahmanuddin S, Borazanci E
Cancer Treat Res
. 2019 Jun;
178:209-236.
PMID: 31209847
Pancreas cancer is an aggressive and fatal disease that will become one of the leading causes of cancer mortality by 2030. An all-out effort is underway to better understand the...
7.
Babiker H, Byron S, Hendricks W, Elmquist W, Gampa G, Vondrak J, et al.
Invest New Drugs
. 2018 Sep;
37(4):636-645.
PMID: 30264293
Malignant melanoma (MM) exhibits a high propensity for central nervous system dissemination with ~50% of metastatic MM patients developing brain metastases (BM). Targeted therapies and immune checkpoint inhibitors have improved...
8.
Infante J, Korn R, Rosen L, LoRusso P, Dychter S, Zhu J, et al.
Br J Cancer
. 2018 Jan;
118(2):e3.
PMID: 29361630
This corrects the article DOI: 10.1038/bjc.2017.327.
9.
Raghunand N, Scicinski J, Guntle G, Jagadish B, Mash E, Bruckheimer E, et al.
Oncotarget
. 2017 Dec;
8(60):102511-102520.
PMID: 29254266
RRx-001 is an anticancer agent that subjects cancer cells to reactive oxygen/nitrogen species (ROS/RNS) and acts as an epigenetic modifier. We have used a thiol-bearing MRI contrast agent, Gd-LC7-SH, to...
10.
Infante J, Korn R, Rosen L, LoRusso P, Dychter S, Zhu J, et al.
Br J Cancer
. 2017 Sep;
118(2):153-161.
PMID: 28949957
Background: Hyaluronan accumulation in tumour stroma is associated with reduced survival in preclinical cancer models. PEGPH20 degrades hyaluronan to facilitate tumour access for cancer therapies. Our objective was to assess...